Indefinite Delivery Contract SPE2DE22D0008

This federal contract IDV award, valued at up to $7,326,120.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Alba Bioscience, Inc., a foreign-owned, for-profit organization. The contract is an Indefinite Delivery Contract with a period of performance through November 28, 2026. Alba Bioscience provides a variety of in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to support the DLA's medical supply needs. Task orders under this contract include delivery of specialized blood banking products such as ALBACYTE antibody screens, ALBACLONE antibodies, ALBAHANCE additives, and ALBASURE quality control kits. These products are critical supplies for blood banking operations across federal agencies, including the Department of Veterans Affairs (VA) and Department of Health and Human Services (HHS), which Alba Bioscience also serves through multiple Blanket Purchase Agreements.

The original solicitation, SPE2DE-17-R-0001, was a pre-solicitation notice for the DLA Troop Support Medical to establish multiple Indefinite Delivery, Indefinite Quantity (IDIQ) contracts for a five-year period to procure laboratory supplies, including reagents, diagnostics, chemicals, and equipment, for various Department of Defense and federal customers. The total estimated value of the contracts awarded was $491,800,000, with a maximum possible value of $983,600,000. The solicitation sought to qualify suppliers who could provide the required laboratory supplies while adhering to the Berry Amendment and Trade Agreements Act. No set-aside designations were used for this procurement.